Detalles de la búsqueda
1.
Safety and efficacy of an α1 -blocker plus mirabegron compared with an α1 -blocker plus antimuscarinic in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia and overactive bladder: A systematic review and network meta-analysis.
Neurourol Urodyn
; 43(3): 604-619, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38291827
Resultados
1 -
1
de 1
1
Próxima >
>>